Both in Medical Labs
Quest Diagnostics vs GRAIL
Over the past year DGX returned +43.6% and GRAL returned +78.0%; their daily moves had a correlation of 0.07.
DGX +43.6% GRAL +78.0%Growth of $1, one year, split-adjusted
| Metric | DGX | GRAL |
|---|---|---|
| Price | $255.68 | $143.66 |
| Market cap | $28.22B | $6.42B |
| Today | +3.49% | +3.03% |
| 1 month | +11.9% | +4.6% |
| 6 months | +35.2% | +128.9% |
| Year to date | +47.3% | +67.8% |
| 1 year | +43.0% | — |
| Revenue growth (YoY) | +10.0% | +25.7% |
| Gross margin | 33.6% | −28.1% |
| Net margin | 10.0% | −246.7% |
| P/E (TTM) | 25.1× | — |
| Price / sales | 2.4× | 38.8× |
| Net cash | -$4.75B | $861.6M |
| Dividend yield | 1.35% | — |
| Volatility (60d) | 22.1% | 96.8% |
| Short % of float | 3.2% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).